Screener
GoodRx Holdings, Inc. GDRX Prescription transactions revenue — Revenue
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by GoodRx Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: GoodRx Holdings, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:09 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001809519-26-000152
| (in thousands) | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Prescription transactions revenue | $106,390 | $143,064 | $220,082 | $291,987 |
| Subscription revenue | 28,514 | 20,463 | 52,907 | 41,480 |
| Pharma Direct revenue | 61,628 | 34,981 | 113,858 | 63,629 |
| Other revenue | 3,879 | 4,562 | 7,570 | 8,944 |
| Total revenue | $200,411 | $203,070 | $394,417 | $406,040 |
Item 1. Financial Statements
FAQ
- What is GoodRx Holdings, Inc.'s prescription transactions revenue — revenue?
- GoodRx Holdings, Inc. (GDRX) reported prescription transactions revenue — revenue of $106.39M in Q2 2026.
- How has GoodRx Holdings, Inc.'s prescription transactions revenue — revenue changed year-over-year?
- GoodRx Holdings, Inc.'s prescription transactions revenue — revenue decreased by 25.6% year-over-year, from $143.06M to $106.39M.
- What is the long-term trend for GoodRx Holdings, Inc.'s prescription transactions revenue — revenue?
- Over 4 years (2021 to 2025), GoodRx Holdings, Inc.'s prescription transactions revenue — revenue has grown at a -2.1% compound annual growth rate (CAGR), from $593.36M to $544M.
- What does prescription transactions revenue — revenue mean?
- This metric represents the total revenue generated from prescription transaction services, primarily derived from fees paid by pharmacy benefit managers or other partners when consumers use the platform to access negotiated drug prices. It serves as a key indicator of the platform's ability to monetize prescription volume and capture value from facilitating healthcare cost savings. Growth in this metric reflects successful user adoption and effective partnership monetization within the digital pharmacy marketplace.
Ask your AI about GoodRx Holdings, Inc.'s prescription transactions revenue — revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude